Intensity Therapeutics, Inc Common stock

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$282
Gross Profit
-6
-6
276
EBITDA
-3,570
-4,965
-4,597
-3,165
EBIT
-4,971
-4,603
-3,171
Net Income
-3,513
-4,971
-4,603
-3,171
Net Change In Cash
0
0
0
282
Free Cash Flow
-3,972
-4,214
-4,366
-947
Cash
2,782
3,241
7,458
8,556
Basic Shares
13,804
13,712
13,709
13,709

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-147
-179
EBITDA
-10,086
-7,402
-8,013
-6,223
EBIT
-10,233
-7,581
-8,013
-6,223
Net Income
-10,538
-7,451
-7,892
-5,956
Net Change In Cash
0
0
0
0
Free Cash Flow
-7,205
-5,477
-6,826
-5,370
Cash
8,556
1,311
4,539
9,316
Basic Shares
8,616
13,099
13,099
13,099

Earnings Calls

Quarter EPS
2024-09-30
-$0.25
2024-06-30
-$0.36
2024-03-31
-$0.34
2023-12-31
-$0.23